Apimeds Pharmaceuticals Us, Inc. · AMEX:APUS
Inscobee Inc. reported a 17.50% stake in Apimeds Pharmaceuticals Us, Inc. (Schedule 13D)
Event May 12, 2025 · Filed May 19, 2025
Inscobee Inc. reported a 17.50% stake in Apimeds Pharmaceuticals Us, Inc., 2,028,657 shares, with active intent on May 12, 2025. Filed May 19, 2025 (Schedule 13D).
- Stake
- 17.50%
- Shares
- 2,028,657
- Intent
- Active
- What changed
- Crossed above 5%
- Filed together
- 2 holders
The filing in full
| Holder | Stake | Shares |
|---|---|---|
| Inscobee Inc. | 17.50% | 2,028,657 |
| Apimeds Inc. | 37.90% | 4,387,708 |
Source
Related
- Apimeds Pharmaceuticals Us, Inc.
- Inscobee Inc.
- Apimeds Pharmaceuticals Us, Inc. shareholders
- Schedule 13D/A · Inscobee Inc. · May 7, 2026
- Schedule 13D/A · Inscobee Inc. · Mar 30, 2026
- Schedule 13D/A · Inscobee Inc. · Mar 20, 2026
- Schedule 13D/A · Inscobee Inc. · Jan 26, 2026
- Schedule 13G · Ayrton Capital LLC · Feb 11, 2026